BJERKHOLT ERIC (CIK 1197350) reported 22 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-08). Recent activity: Sell MIRM (3,124 shares), Sell MIRM (1,048 shares), Sell MIRM (528 shares), Sell MIRM (300 shares), Sell CERS (20,454 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 3,124 | $380,097 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 1,048 | $128,307 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 528 | $65,388 |
| 2026-07-08 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 300 | $37,482 |
| 2026-06-11 | CERUS CORP (CERS) | Director | Sell | 20,454 | $53,180 |
| 2026-06-09 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 2,258 | $209,633 |
| 2026-06-09 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 1,175 | $110,391 |
| 2026-06-09 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 1,567 | $149,053 |
| 2026-06-09 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Buy | 2,393 | $63,391 |
| 2026-06-02 | CERUS CORP (CERS) | Director | Buy | 60,000 | $0 |
| 2026-03-17 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Buy | 13,334 | $0 |
| 2026-03-17 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 7,287 | $670,258 |
| 2026-01-27 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Buy | 2,667 | $0 |
| 2026-01-27 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 1,053 | $101,288 |
| 2026-01-23 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Buy | 3,334 | $0 |
| 2026-01-23 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 1,421 | $132,622 |
| 2025-09-12 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Buy | 18,333 | $0 |
| 2025-09-12 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 9,578 | $728,024 |
| 2025-08-12 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Sell | 8,000 | $0 |
| 2025-08-12 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Buy | 2,954 | $78,251 |
| 2025-06-04 | CERUS CORP (CERS) | Director | Buy | 60,000 | $0 |
| 2025-01-27 | Mirum Pharmaceuticals, Inc. (MIRM) | CHIEF FINANCIAL OFFICER | Buy | 2,667 | $0 |
Source: SEC Form 4 filings · as of 2026-07-08